
Enko designs safe and sustainable solutions to farmers' most urgent crop threats, from pest resistance to new diseases. By applying healthcare's drug discovery approach to plants, Enko is bringing an innovation model to agriculture and meeting farmers' evolving needs. Founded in 2017 and led by a team of proven scientists, entrepreneurs and agriculture industry veterans, Enko is backed by investors including the Gates Foundation, Anterra Capital and Novalis LifeSciences.